N-(2-cyclohexyl-8-nitroso-5,6-dihydrobenzo[f]quinoxalin-3-yl)-2-naphthalen-2-ylacetamide
C30H28N4O2 — CID 143000137
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-cyclohexyl-8-nitroso-5,6-dihydrobenzo[f]quinoxalin-3-yl)-2-naphthalen-2-ylacetamide
N-(2-cyclohexyl-8-nitroso-5,6-dihydrobenzo[f]quinoxalin-3-yl)-2-naphthalen-2-ylacetamide (PubChem CID 143000137) has the molecular formula C30H28N4O2 and a molecular weight of 476.58 g/mol. Its IUPAC name is N-(2-cyclohexyl-8-nitroso-5,6-dihydrobenzo[f]quinoxalin-3-yl)-2-naphthalen-2-ylacetamide.
Molecular Properties
| Compound Name | N-(2-cyclohexyl-8-nitroso-5,6-dihydrobenzo[f]quinoxalin-3-yl)-2-naphthalen-2-ylacetamide |
|---|---|
| PubChem CID | 143000137 |
| Molecular Formula | C30H28N4O2 |
| Molecular Weight | 476.58 g/mol |
| Exact Mass | 476.22 |
| IUPAC Name | N-(2-cyclohexyl-8-nitroso-5,6-dihydrobenzo[f]quinoxalin-3-yl)-2-naphthalen-2-ylacetamide |
| SMILES | O=Nc1ccc2c(c1)CCc1nc(NC(=O)Cc3ccc4ccccc4c3)c(C3CCCCC3)nc1-2 |
| InChI | InChI=1S/C30H28N4O2/c35-27(17-19-10-11-20-6-4-5-9-22(20)16-19)32-30-28(21-7-2-1-3-8-21)33-29-25-14-13-24(34-36)18-23(25)12-15-26(29)31-30/h4-6,9-11,13-14,16,18,21H,1-3,7-8,12,15,17H2,(H,31,32,35) |
| InChIKey | SYXQRURLBYZVJK-UHFFFAOYSA-N |
| XLogP | 7.02 |
| TPSA | 84.31 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.58 |
| LogP ≤ 5 | 7.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143000137 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.